Regulation of rbST in the US

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

In the United States (US) and European Union (EU) the regulatory and commercialization process for recombinant bovine somatotropin (rbST) had widely differing outcomes. Although the regulatory process in both locations was completed in 1993 the commercialization of rbST in the US has been highly successful while completely failing in the EU. This paper examines these events from the US perspective and concludes that reasons for the difference in commercial success lie in the cultural, regulatory, and political background differences between the two world locations.

Original languageEnglish (US)
Pages (from-to)156-163
Number of pages8
JournalAgBioForum
Volume3
Issue number2-3
StatePublished - 2000

Fingerprint

somatotropin
Growth Hormone
commercialization
European Union
bovine growth hormone
Bovine
Recombinant
Commercialization

Keywords

  • Dairy cattle
  • Public acceptance
  • Regulatory process
  • Somatotropin

ASJC Scopus subject areas

  • Agronomy and Crop Science
  • Biotechnology

Cite this

Regulation of rbST in the US. / Collier, Robert J.

In: AgBioForum, Vol. 3, No. 2-3, 2000, p. 156-163.

Research output: Contribution to journalArticle

Collier, RJ 2000, 'Regulation of rbST in the US', AgBioForum, vol. 3, no. 2-3, pp. 156-163.
Collier, Robert J. / Regulation of rbST in the US. In: AgBioForum. 2000 ; Vol. 3, No. 2-3. pp. 156-163.
@article{8a3ba813a24643049f794ae54e26e16a,
title = "Regulation of rbST in the US",
abstract = "In the United States (US) and European Union (EU) the regulatory and commercialization process for recombinant bovine somatotropin (rbST) had widely differing outcomes. Although the regulatory process in both locations was completed in 1993 the commercialization of rbST in the US has been highly successful while completely failing in the EU. This paper examines these events from the US perspective and concludes that reasons for the difference in commercial success lie in the cultural, regulatory, and political background differences between the two world locations.",
keywords = "Dairy cattle, Public acceptance, Regulatory process, Somatotropin",
author = "Collier, {Robert J}",
year = "2000",
language = "English (US)",
volume = "3",
pages = "156--163",
journal = "AgBioForum",
issn = "1522-936X",
publisher = "University of Missouri",
number = "2-3",

}

TY - JOUR

T1 - Regulation of rbST in the US

AU - Collier, Robert J

PY - 2000

Y1 - 2000

N2 - In the United States (US) and European Union (EU) the regulatory and commercialization process for recombinant bovine somatotropin (rbST) had widely differing outcomes. Although the regulatory process in both locations was completed in 1993 the commercialization of rbST in the US has been highly successful while completely failing in the EU. This paper examines these events from the US perspective and concludes that reasons for the difference in commercial success lie in the cultural, regulatory, and political background differences between the two world locations.

AB - In the United States (US) and European Union (EU) the regulatory and commercialization process for recombinant bovine somatotropin (rbST) had widely differing outcomes. Although the regulatory process in both locations was completed in 1993 the commercialization of rbST in the US has been highly successful while completely failing in the EU. This paper examines these events from the US perspective and concludes that reasons for the difference in commercial success lie in the cultural, regulatory, and political background differences between the two world locations.

KW - Dairy cattle

KW - Public acceptance

KW - Regulatory process

KW - Somatotropin

UR - http://www.scopus.com/inward/record.url?scp=3042532344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042532344&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:3042532344

VL - 3

SP - 156

EP - 163

JO - AgBioForum

JF - AgBioForum

SN - 1522-936X

IS - 2-3

ER -